Tag: Aflibercept

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aflibercept

AAO 2024: The Impact of New Data and Expanded Access in DME - Medscape

Added to Collection on: 2024-11-05 21:57:05

Tags for this article:

Angiogenesis inhibitors
Macular edema
Aflibercept
Diabetic retinopathy
DME
Sunir J. Garg

Click the tags to see associated articles and topics

View Article Details
28 Analysts Have This To Say About Regeneron Pharmaceuticals - Benzinga

Added to Collection on: 2024-11-14 19:19:26

Tags for this article:

Sanofi
Monoclonal antibodies
Regeneron Pharmaceuticals
PCSK9 inhibitors
Alirocumab
Aflibercept
Financial market

Click the tags to see associated articles and topics

View Article Details
Amgen Launches Pavblu™ as the First EYLEA® Biosimilar in the U.S. | JD Supra

Added to Collection on: 2024-11-15 19:59:33

Tags for this article:

Sanofi
Aflibercept
Biosimilar
Regeneron Pharmaceuticals
Injunction
Biocon
Amgen
United States patent law
Regeneron
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In ...

Added to Collection on: 2024-12-17 18:10:35

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Macular edema
Regeneron Pharmaceuticals
Central retinal vein occlusion
Bayer
Diabetic retinopathy
Macular degeneration
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Personal Jurisdiction Over Foreign Companies that File an ANDA or aBLA in the U.S. - JD Supra

Added to Collection on: 2025-01-31 19:57:43

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Biosimilar
Monoclonal antibodies
Samsung
Injunction
United States

Click the tags to see associated articles and topics

View Article Details
European Medicines Agency CHMP adopts positive opinions for two aflibercept biosimilars

Added to Collection on: 2025-02-03 18:29:55

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Monoclonal antibodies
Biosimilar
Macular edema
Committee for Medicinal Products for Human Use
European Medicines Agency
Macular degeneration
CHMP
Ranibizumab
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron Misses on Eylea, Dupixent Sales; Issues First-Ever Dividends - BioSpace

Added to Collection on: 2025-02-04 15:25:53

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Leonard Schleifer
Aflibercept
Pharmaceutical industry
Blockbuster
Macular edema
Tuesday Morning
Dupilumab
Eylea

Click the tags to see associated articles and topics

View Article Details
REGENERON PHARMACEUTICALS, INC. SEC 10-K Report - TradingView

Added to Collection on: 2025-02-05 16:20:34

Tags for this article:

Regeneron Pharmaceuticals
Sanofi
Biosimilar
Pharmaceuticals policy
Bayer
Aflibercept
Pharmaceutical industry
Healthcare in the United States
Eylea
United States

Click the tags to see associated articles and topics

View Article Details
Regeneron Pharmaceuticals Inc (REGN) Announces Positive Phase 3 - GuruFocus

Added to Collection on: 2025-02-08 23:20:43

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Macular edema
Central retinal vein occlusion
Regeneron Pharmaceuticals
Anti-VEGF
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
FDA to review Sanofi and Regeneron's Dupixent sBLA for bullous pemphigoid

Added to Collection on: 2025-02-18 17:20:37

Tags for this article:

Sanofi
Autoimmune diseases
CAC 40
Dupilumab
Regeneron Pharmaceuticals
Immunology
Type 2 inflammation
Pemphigoid
Atopic dermatitis
Aflibercept
Bullous pemphigoid
Interleukin 13
Regeneron

Click the tags to see associated articles and topics

View Article Details